Aljehani A, Baig S, Kew T, Kalla M, Sommerfeld LC, Murukutla VA, Fabritz L, Steeds RP. Structural Progression in Patients with Definite and Non-Definite Arrhythmogenic Right Ventricular Cardiomyopathy and Risk of Major Adverse Cardiac Events. Biomedicines. 2024 Jan 31;12(2):328. doi: 10.3390/biomedicines12020328. PMID: 38397930; PMCID: PMC10886648.
Sommerfeld LC, Holmes AP, Yu TY, O'Shea C, Kavanagh DM, Pike JM, Wright T, Syeda F, Aljehani A, Kew T, et al, . Reduced plakoglobin increases the risk of sodium current defects and atrial conduction abnormalities in response to androgenic anabolic steroid abuse. J Physiol. 2024 Feb 12. doi: 10.1113/JP284597. Epub ahead of print. PMID: 38345865.
Aljehani, A., Kew, T., Baig, S. et al. Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC). BMC Cardiovasc Disord 23, 14 (2023). https://doi.org/10.1186/s12872-022-03021-w
Aljehani A, Steeds R, sommerfeld L, et al. Progression of arrhythmogenic right ventricular cardiomyopathy (arvc) and risk of major adverse cardiac eventsHeart 2023;109:A204.